EligibleTrials

Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems

Recruiting · NCT06391073 · Interventional (participants receive a specific treatment)

View the official record on ClinicalTrials.gov →
Hypertension

Interventions studied

Physician appointment and transportation schedulingSelf-Measured Blood Pressure Monitoring

What this trial is about

Emergency department visits provide an opportunity to identify people with undiagnosed, untreated, or uncontrolled high blood pressure. In Reach Out, we will test whether a mobile health intervention yields a greater reduction in blood pressure than usual care among individuals identified with high blood pressure during a safety-net emergency department visit. Subsequently, we will estimate the reduction in heart attack, stroke, and dementia if Reach Out were implemented across all U.S. safety-net emergency departments.

Who can take part

Age range
18 Years to 99 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Eligibility criteria (as published)

While in the ED, the patient must meet all of the following: * Adult (≥18 y/o) * At least one BP with Systolic BP ≥160 or a Diastolic BP ≥100 (criteria 1) * If the patient has repeated measurements after achieving Criteria 1, at least one of the repeat BP remains systolic BP ≥140 or a diastolic BP ≥90 * Must have cell phones with text-messaging capability * Likely to be discharged from the ED Exclusion Criteria for Main Trial Participants: * Critical illness * Unable to read English (\<1% at study site) * Incarcerated * Pregnant * Pre-existing condition making 6-month follow-up unlikely

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.